SmallCap
CompaniesMapStatistics

(주)이을바이오사이언스

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)이을바이오사이언스
Business Reg. No.4818702659
CEO김승찬
Address서울 서초구
Industry화장품 제조업
Industry Code20423
Main Products줄기세포 유래 엑소좀
EstablishedContact
Phone02-536-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.110111-*******

Investment Metrics


Market Cap
-
Op. Margin
10.68%
ROE
-10.57%
Debt Ratio
409.02%

Certification Status


Venture Certified

Cert. History
벤처투자유형2023-01-25 ~ 2026-01-24202301250100482023-01-25
벤처투자유형2026-01-25 ~ 2029-01-24202512230100442023-01-25

Financial Statements


3-Year Financial Data

Revenue CAGR +933.9%

Item202420232022
Revenue

105B

10B

0.0B

Operating Profit

11B

0.6B

-3.1B

Net Profit

-4.2B

0.1B

-3.1B

Total Assets

205B

101B

12B

Total Liabilities

164B

83B

0.3B

Total Equity

40B

17B

11B

Risk Indicators


1 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
105B

1967.7%

vs. 3-Year Avg.: 5B
Operating Profit
11B

976.7%

vs. 3-Year Avg.: -1B
Op. Margin
10.7%

96.3%

vs. 3-Year Avg.: 5.4%
Debt Ratio
409.0%

69.6%

vs. 3-Year Avg.: 241.2%
ROE
-10.6%

20.9%

vs. 3-Year Avg.: -13.4%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김승찬대표이사대표

Employment Status


Regular EmployeesContact
CEO김승찬

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울 서초구",
  "ceo_name": "김승찬",
  "certificate": [
    {
      "cert_number": "20230125010048",
      "changes": "",
      "disclosure_date": "2023-01-25",
      "first_cert_date": "2023-01-25",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2023-01-25 ~ 2026-01-24"
    },
    {
      "cert_number": "20251223010044",
      "changes": "",
      "disclosure_date": "2025-12-23",
      "first_cert_date": "2023-01-25",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2026-01-25 ~ 2029-01-24"
    }
  ],
  "company_name": "(주)이을바이오사이언스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 11094000,
      "cost_of_sales": 0,
      "current_assets": 855717000,
      "current_liabilities": 28640000,
      "gross_profit": 0,
      "net_income": -307540000,
      "net_income_bs": -307540000,
      "non_current_assets": 298383000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 5000,
      "non_operating_income": 3669000,
      "operating_profit": -311204000,
      "revenue": 0,
      "sga_expenses": 311204000,
      "total_assets": 1154100000,
      "total_equity": 1125460000,
      "total_liabilities": 28640000
    },
    "2023": {
      "capital_stock": 11228000,
      "cost_of_sales": 378100000,
      "current_assets": 2842958000,
      "current_liabilities": 7670996000,
      "gross_profit": 637679000,
      "net_income": 10572000,
      "net_income_bs": 10572000,
      "non_current_assets": 7241920000,
      "non_current_liabilities": 674850000,
      "non_operating_expenses": 47670000,
      "non_operating_income": 2969000,
      "operating_profit": 55273000,
      "revenue": 1015779000,
      "sga_expenses": 582406000,
      "total_assets": 10084878000,
      "total_equity": 1739032000,
      "total_liabilities": 8345846000
    },
    "2024": {
      "capital_stock": 11227000,
      "cost_of_sales": 4798127000,
      "current_assets": 11697248000,
      "current_liabilities": 2925247000,
      "gross_profit": 5703701000,
      "net_income": -424909000,
      "net_income_bs": -425821000,
      "non_current_assets": 8766015000,
      "non_current_liabilities": 13517883000,
      "non_operating_expenses": 1555768000,
      "non_operating_income": 9025000,
      "operating_profit": 1121834000,
      "revenue": 10501828000,
      "sga_expenses": 4581867000,
      "total_assets": 20463263000,
      "total_equity": 4020133000,
      "total_liabilities": 16443130000
    }
  },
  "industry": "화장품 제조업",
  "investment": [
    {
      "amount": "414,000,000",
      "changes": "414,000,000",
      "date": "2022-11-22"
    },
    {
      "amount": "414,000,000",
      "changes": "414,000,000",
      "date": "2022-11-22"
    }
  ],
  "main_products": "줄기세포 유래 엑소좀",
  "phone": "02-536-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected